← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2009Last known activity
Nov 30, 2020
Timeline
1920s
- Jun 1, 1922
Asahi Kasei Pharma— Founded
2010s
- Nov 1, 2011
Artisan Pharma, Inc.— Acquired
- Nov 26, 2019
Veloxis Pharmaceuticals— Acquired
2020s
- Sep 13, 2021
Itamar-Medical, Israel— Acquired
Drugs by trial phase (26 distinct, 59 trials)
Phase 4 (0 own, 8 via acquisition)
Phase 3 (6 own, 3 via acquisition)
Phase 2 (3 own, 2 via acquisition)
Phase 1 (2 own, 2 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Blood Coagulation Disorders
- Colonic Neoplasms
- Constriction, Pathologic
- Contracture
- Disseminated Intravascular Coagulation
- Dupuytren Contracture
- Fibrosis
- Hemiplegia
- Hemostatic Disorders
- Idiopathic Pulmonary Fibrosis
- Lupus Nephritis
- Mycoses
- Nephritis
- Nephrosis
- Nephrotic Syndrome
- Osteoporosis
- Peripheral Nervous System Diseases
- Pulmonary Fibrosis
- Sepsis
- Spinal Stenosis
- Spondylolisthesis
- Syndrome
- Toxemia
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (25)
- NCT04492436Study directorPhase 2Nov 30, 2020
- NCT04492436Lead sponsorPhase 2Nov 30, 2020
- NCT04483297Lead sponsorPhase 1Oct 31, 2020
- NCT03517501Lead sponsorPhase 3Jul 31, 2018
- NCT03517501Study directorPhase 3Jul 31, 2018
- NCT03471988Lead sponsorPhase 3Apr 16, 2018
- NCT02792842Study chairPhase 2Jul 1, 2016
- NCT02792842Lead sponsorPhase 2Jul 1, 2016
- NCT02739165Study chairPhase 3May 1, 2016
- NCT02739165Lead sponsorPhase 3May 1, 2016
- NCT02257697Study chairPhase 3Nov 1, 2014
- NCT02256150Study chairPhase 3Nov 1, 2014
- NCT02256150Lead sponsorPhase 3Nov 1, 2014
- NCT02257697Lead sponsorPhase 3Nov 1, 2014
- NCT01935479Lead sponsorPhase 1Aug 1, 2013
Details
- Founded
- Tokyo, JP Jun 1, 1922
- Last known activity
- Nov 30, 2020